Shah Gaurav

CIK 00017259222 companiesCRANBURY, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001725922

Recent Transactions

50 trades

Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2026-02-18$3.34/sh−5,990→ 1,046,055 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2026-02-13$3.31/sh−12,279→ 1,052,045 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2026-02-11+286,028→ 1,064,324 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2026-02-11+870,648→ 870,648 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2025-11-18$2.98/sh−6,276→ 778,296 total
Tax Payment
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2025-08-18$3.05/sh−2,234→ 784,572 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2025-05-20$6.45/sh−2,253→ 786,806 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2025-05-16$6.53/sh−3,621→ 789,059 total
Purchase
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2025-04-10$5.08/sh+20,000→ 792,680 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2025-02-21$10.58/sh−16,303→ 772,680 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2025-02-11+243,345→ 243,345 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2025-02-11+81,655→ 788,983 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2024-11-21$13.05/sh−11,091→ 707,328 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2024-08-16$18.50/sh−9,650→ 718,419 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2024-05-16$23.35/sh−9,790→ 728,069 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2024-05-14−7,979→ 23,940 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2024-05-14−9,683→ 67,785 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2024-05-14+9,683→ 646,134 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2024-05-14+7,979→ 636,451 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2024-02-16+196,336→ 196,336 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2024-02-16+66,577→ 621,339 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2024-02-16$29.84/sh−20,272→ 554,762 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2024-02-14−38,849→ 77,468 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2024-02-14−7,979→ 31,919 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2024-02-14−46,828→ 575,034 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2023-11-14−7,979→ 532,833 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2023-11-14−7,979→ 39,898 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2023-08-17$15.47/sh−4,767→ 524,854 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2023-08-14−7,979→ 47,877 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2023-08-14+7,979→ 529,621 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2023-06-13+20,500→ 20,500 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2023-05-17$21.38/sh−4,122→ 521,642 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2023-05-14−7,979→ 55,856 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2023-05-14+7,979→ 525,764 total
Sale
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2023-02-17$19.06/sh−12,194→ 536,885 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2023-02-14+116,317→ 116,317 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2023-02-14+116,317→ 116,317 total
Other
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2023-02-14+67,785→ 737,859 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2023-02-14+31,440→ 549,079 total
Exercise/Conversion
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2023-02-14+31,440→ 63,835 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2023-02-14+348,590→ 348,590 total
Other
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2023-02-14−67,785→ 0 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2023-02-14+348,590→ 348,590 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2022-06-09+14,501→ 14,501 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2022-02-14+95,275→ 95,275 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2022-02-14+297,037→ 297,037 total
Other
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2022-02-14+23,940→ 670,074 total
Other
ROCKET PHARMACEUTICALS, INC.$RCKT
Restricted Stock Units
2022-02-14−23,940→ 0 total
Purchase
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2022-02-07$17.34/sh+22,000→ 517,639 total
Tax Payment
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2021-04-01$46.45/sh−8,872→ 503,114 total

Companies

Recent Filings

Address

C/O ROCKET PHARMACEUTICALS, INC. 9 CEDARBROOK DRIVE

CRANBURY, NJ, 08512

View on SEC.gov